Literature DB >> 20504790

Antithrombin-III attenuates hepatocyte apoptosis in bile duct ligated rat: a striking cellular change.

Chun-Ying Huang1, Shyr-Ming Sheen-Chen, Hsin-Tsung Ho, Rei-Ping Tang, Hock-Liew Eng.   

Abstract

BACKGROUND AND
PURPOSE: Retention and accumulation of toxic hydrophobic bile salts within hepatocyte may cause hepatocyte toxicity by inducing apoptosis. This study was designed with the purpose of evaluating the possible effect of antithrombin-III on hepatocyte apoptosis in bile duct ligated rat.
MATERIALS AND METHODS: The rats were randomized to 3 groups: group 1 (control, C) underwent sham operation; group 2 (obstructive jaundice, OB) underwent common bile duct ligation; and group 3 (obstructive jaundice with antithrombin-III, OBAT-III) underwent common bile duct ligation and simultaneously were treated with antithrombin-III. Liver tissues were harvested on the fifth postoperative day.
RESULTS: Hepatocyte apoptosis was significantly increased in bile duct ligated group when compared with the sham operation group. The administration of antithrombin-III effectively attenuates such phenomenon in obstructive jaundice with antithrombin-III group.
CONCLUSION: Bile duct ligation significantly increased hepatocyte apoptosis and the administration of antithrombin-III effectively attenuates such phenomenon.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504790     DOI: 10.1177/1553350610366716

Source DB:  PubMed          Journal:  Surg Innov        ISSN: 1553-3506            Impact factor:   2.058


  3 in total

1.  CANDIDATE GENES FOR LIMITING CHOLESTATIC INTESTINAL INJURY IDENTIFIED BY GENE EXPRESSION PROFILING.

Authors:  Samuel M Alaish; Jennifer Timmons; Alexis Smith; Marguerite S Buzza; Ebony Murphy; Aiping Zhao; Yezhou Sun; Douglas J Turner; Terez Shea-Donahue; Toni M Antalis; Alan Cross; Susan G Dorsey
Journal:  Physiol Rep       Date:  2013-09

2.  Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study.

Authors:  Bijar Ghafouri; Anders Carlsson; Sara Holmberg; Anders Thelin; Christer Tagesson
Journal:  BMC Musculoskelet Disord       Date:  2016-05-10       Impact factor: 2.362

3.  Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase.

Authors:  Ginés Luengo-Gil; María Inmaculada Calvo; Ester Martín-Villar; Sonia Águila; Nataliya Bohdan; Ana I Antón; Salvador Espín; Francisco Ayala de la Peña; Vicente Vicente; Javier Corral; Miguel Quintanilla; Irene Martínez-Martínez
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.